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David P. Foley, Rein Melkert, Victor A. Umans, Peter P. de Jaegere, Patrick
W. Serruys Thoraxcentre, Erasmus University, Rotterdam, Netherlands
Left anterior descending (LAD) coronary artery location is reported to be
associated with increased propensity to restenosis after intervention. This
study, in 3736 patients, investigates whether this finding is equally applicable
to intervention with balloon angioplasty (BA, n = 3797 lesions), directional
atherectomy (DCA, n = 200 lesions), Palmaz-Schatz stent implantation (PS,
n ~ 229 lesions) and excimer laser angioplasty (ELCA, n = 116 lesions). Au-
tomated core laboratory quantitative analysis (OCA) was performed in mul-
tiple matched angiographic projections pre and post intervention and at 6
month follow up (overall QCA follow up 93%). Multiple linear regression
analysis was employed to determine whether LAD lesion location was asso-
ciated with greater propensity to luminal renarrowing, independently of le-
sion severity pre, procedural luminal increase and reference vessel diameter.
Because of the large variation in vessel size, lumen renarrowing was mea-
sured as relative luminal loss (minimal luminal diameter (MLD) post-follow
up/reference diameter pre) and angiographic outcome as relative lumen at
follow up (MLD at follow up/reference diameter pre). In multivariate analysis
applied to the entire patient population, LAD location was independently as-
sociated with greater relative loss and smaller lumen at follow up (p = 0.007).
However, application of the model to each patient group separately, revealed
analogous findings for the DCA (p = 0.003) and BA (p = 0.03) groups, but no
significant association between LAD location and late angiographic results
was evident in the PS (p = 0.18) or ELCA (p = 0.55) groups. Retrospective
exclusion of totally occluded lesions at baseline and/or at follow up from the
analysis did not appreciable alter these findings.
Conclusion: LAD lesions were independently associated with less
favourable late angiographic results after balloon angioplasty or directional
atherectomy, whereas late results after Palmaz-Schatz stent implantation or
excimer laser angioplasty did not vary with lesion location. In contrast with
previous reports, these findings suggest a differential influence of lesion lo-
cation on late interventional results, depending on the device used. Accord-
inglyfurther investigation will be required for clarification of this association.
(OR = 2.31, P < 0.05) failure. Although no ELCA effect was noted for late clin-
ical outcome (p = 0.56), a trend toward more ELCA-related events was seen
in TLR (RR = 1.43; P = 0.06). In conclusion: In lesion subsets suitable for
treatment with either device, ELCA-treated patients had: 1) lower Proc-S: 2)
more acute complications; and 3) a trend toward more frequent TLR than
RA-treated patients.
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Influence of Epicardial Lesion Location on Late
Luminal Renarrowing and Angiographic Outcome
After Successful Balloon Angioplasty, Directional
Atherectomy, Stent Implantation and Excimer Laser
Angioplasty
PSS DCA Balloon P
Lesion success (%) 117(95.9) 102 (944) 920 (95.3) 0.87
MLD post (mm) 2.87 ± 0.67 2.84 ± 0.77 2.20 ± 0.96 0.0001
In hospital death (%) 1 (0.9) 0(0.0) 410.5) 0.63
O-Wave MI (%) 2(1.8) 1(1.0) 15 (1.8) 0.85
CABG{%) 5(4.3) 3(2.9) 30(3.5) 0.84
6 months follow-up
PTCA(%) 31 (35) 30 (31) 247 (31) 0.74
CABG(%) 19 (22) 21 (22) 141 (19) 058
Recurrent angina (%) 34(37) 34(34) 340 (42) 0.25
Death (%) 918.5) 4 (39) 37 (4.3) 0.14
Both Palmaz-Schatz stents (PSS) and directional atherectomy (DCA) are re-
ported to be suitable for treating restenotic lesions and claim to decrease
subsequent restenosis. The purpose of this study was to compare in hos-
pital outcome and follow-up (FU) of these two technologies with balloon
angioplasty. Records of 1087 patients with restenosis that underwent elec-
tive (PSS) implantation (116 patients, 122 lesions). DCA (103 patients, 108
lesions), balloon angioplasty in 868 patients, 965 lesions) from January 1988
to March 1994 were reviewed. Mean follow-up was 1.22 ± 0.73 years.
Balloon Angioplasty, Palmaz-Schatz Stent, and
Directional Coronary Atherectomy for Restenotic
Lesions: Retrospective Comparison In a Single
Center
Ron Waksman, William S. Weintraub, Ziyad MB. Ghazzal, John S. Douglas Jr,
Yannan Shen, Spencer B. King III. Emory University School of Medicine, Atlanta, GA
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None of the comparisons were significantly different.
Conclusion: Excimer Laser Angioplasty compared to Balloon Angioplasty
in long coronary lesions yields similar results with respect to longterm clinical
and angiographic outcome.
None of the comparisons were significantly different.
Conclusion: Excimer Laser Angioplasty compared to Balloon Angioplasty
in functional and total coronary occlusion yields similar results with respect
to longterm clinical and angiographic outcome.
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1782-21 Longterm Outcome of Excimer Laser Angioplasty
Versus Balloon Angloplasty in Functional and Total
Coronary Occlusions
Yolande E.A. Appelman, Jacques J. Koolen, Pim J. de Feyter, Sipke Strikwerda,
George K. David, Ken Redekop, Eline v. SWijndregt, Patrick W. Serruys, Jan
G. Tijssen, Jan J. Piek, AMRO study group. The Netherlands
From September 1991 until November 1993 we randomized 103 patients
with functional and total coronary occlusions to Excimer Laser Coronary An-
gioplasty (ELCA, n = 49) or Balloon Angioplasty (BA, n = 54) as part of a
multi-center trial (AMRa) comparing ELCA versus BA in type B or C-Iesions.
We report on the longterm clinical and angiographic outcome of this sub-
group. Procedural success (PS) was defined as <50% residual stenosis at the
end of the procedure. Clinical endpoints were: death (D), myocardial infarc-
tion (MI), coronary bypass surgery (CABG) or repeat angioplasty (re-PTCA) of
the randomized segment within 6 months follow-up. Angiographic endpoint
was the net gain (NG) in minimal lumen diameter at six months follow-up
relative to the pre-procedural baseline determined by a computer-assisted
automated edge detection algorithm (CAAS II). Functional status (FS) at six
months was graded according to the Canadian Cardiovascular Society clas-
sification.
Results: Baseline patient characteristics were similar in both groups. ELCA
was followed by BA in all patients. Re-occlusion of the treated segment dur-
ing 6 months follow-up was 33% in the ELCA group versus 23% in the BA
group (not significant).
1782-31 Rotational Atherectomy vs. Excimer Laser
Angioplasty: A Multi-variable Analysis of Early and
Late Procedural Outcome
Gaston R. Dussaillant, Jeffrey J. Popma, Augusto D. Pichard, Lowell F. Satler,
Kenneth M. Kent, Ya Chien Chuang, Theresa A. Bucher, Benjamin Kleiber,
Anand Desai, Martin B. Leon Washington Hospital Center. Washington, DC
Rotational atherectomy (RA) and excimer laser angioplasty (ELCA) are com-
monly used in lesions unsuitable for balloon angioplasty, but few compara-
tive outcome studies have been performed using these devices in matched
subsets. To address this issue, we reviewed the clinical course of 696 pa-
tients undergoing RA or ELCA in lesions suitable for either technique. Vein
grafts, long (e::20 mm), heavily calcified, thrombus-containing lesions, and to-
tal occlusions were excluded. Angiographic «50% final stenosis), procedu-
ral (proc-S) «50% stenosis and no in-hospital complications [death, Q-wave
myocardial infarction QWMI or CABGI and clinical (Proc-S without rePTCA
<14 days) success, and late events (death, QWMI, target lesion revascu-
larization [TLR, CABG or repeat PTCA)) were recorded for 12 months af-
ter the procedure. Multivariate logistic regression analysis was performed
to evaluate the ELCA effect, accounting for disparities in clinical (unstable
angina, diabetes, multivessel disease) and angiographic (AHA/ACC classifi-
cation, restenosis, length, calcium, eccentricity, angulation, irregularity, and
pre-%DS) variables. ELCA remained an independent predictor for angio-
graphic (OR'" 3.72, P < 0.0051, procedural (OR = 2.96, P < 0.01), and clinical
t p < 005, ttp < 0.01, ttt p < 0.001
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To define the prevalence and fate of residual shunts after Gianturco coil oc-
clusion of patent ductus arteriosus (PDA), 50 pts were followed prospec-
tively after PDA coil occlusion at CS Mott Children's Hospital between 10/92
and 8/94. Evidence of residual shunt was sought on immediate post-coil aor-
tic angiograms and on color-flow Doppler echocardiograms performed in
follow-up. Survival analysis of residual PDA shunting was analyzed by the
Kaplan-Meier method, and the effect of minimum PDA angiographic size on
residual shunting was determined by ANOVA. The 50 pts, median age 4.4
years (range 0.4-621, have been followed for ~20 months (mean ± SD: 8 ±
6). PDA minimum diameter was 1.6 ± 0.8 mm (range 0.5--3.3). Complete PDA
occlusion was noted immediately in 29 pts (58%); tiny residual shunts closed
spontaneously 1-20 months after coil occlusion in 12 pts (24%). Tiny resid-
ual shunts persisted have undergone a second coil occlusion with immediate
complete closure. Survival analysis (graph) estimates 20 month prevalence
of residual shunts at 7 ± 6% after 1 coil procedure and 4 ± 4% after all coil
procedures. PDA diameter significantly influenced residual shunting, being
1.3 ± 0.7 mm in pts with immediate closure, 1.9 ± 0.8 mm with spontaneous
shunt closure in follow-up, and 2.0 ± 0.9 mm with persistent residual shunt
or second coil placement (p = 0.02).
trial, 40 patients received the dilatable banding prosthesis. Banding was suc-
cessful and uncomplicated. No migration of the prosthesis occurred. In only
1 patient was the band adjusted too tightly at implantation. The device was
never adjusted too loosely. There were 11 deaths. None were related to the
prosthesis. Dilatation was performed on 7 patients. This was successful in
6 and uncomplicated in all except 1 who developed a transient heart block.
The dilatable band prosthesis was explanted readily and completely in all
27 patients during their definitive surgery. In 7 patients stenosis of a pul-
monary artery branch developed as a result of distal implantation of the de-
vice. Balloon dilatation improved the stenosis in 2 of the patients. Surgical
pulmonary artery angioplasty was performed mn all 15 patients having to-
tal correction (TC) and in 4 of the 12 patients who had a bidirectional Glenn
procedure (BDGP) and Damus-Kaye-Stanzel connection (DKSC). The duration
of banding of the patients who had (TC) was 31 to 1139 (mean 339) days.
The duration of banding of the patients who had BDGP and DKSC was 88 to
594 (mean 215) days. The longest period of banding was 1640 days. Macro-
scopic and radiographic examination of all 28 explanted devices revealed no
evidence of wear or damage. Scanning electron microscopic examination
was conducted on 5 of the explanted devices which had been implanted
159 to 1139 (mean 422) days. One of the 5 had been successfully dilated.
No component failure was identified. The materials remained inert.
Conclusion: The dilatable band prosthesis is as safe and effective to use
as the conventional fixed fabric band. It is more readily explanted completely
and provides a safe non-surgical option for dilatation.
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Follow-up After Coil Occlusion of Patent Ductus
Arteriosus
David Shim, Raymond T. Fedderly, Robert H. Beekman, Achi Ludomirsky, Mary
L. Young, M. Anthony Schork, Thomas R. lloyd. C.S. Matt Children's Hospital, The
University of Michigan. Ann Arbor, MI
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Acute myocardial infarction (AMI) patients with an infarct related artery (IRA)
containing thrombus are a high risk group for percutaneous transluminal
coronary angioplasty. TEC may be a useful device for treatment of these
patients due to its ability to aspirate thrombus. TEC was prospectively eval-
uated in 63 patients (age 61 ± 12 years) including 23 (36.5%) ineligible for
thrombolysis, 24 (38%) with lytic failure, and 16 (25.5%) with post infarct
angina and a thrombotic coronary occlusion. Immediate, one week, and six
month angiographic and clinical followup were obtained. The IRA was a SVG
in 18 (29%) and a native coronary artery (NAT) in 45 (71 %). Acute procedu-
ral success with a residual stenosis <50% and TIMI 2 or 3 grade flow was
acheived in 94% of patients. There were no major procedural complications.
Other events during the hospitalization included death in 3 (4.8%), CABG in
2 (3%) and blood transfusion in 12 (19%). Elective predischarge angiography
revealed an IRA stenosis <50% in 34/38 (89%). Patients were followed for 6
months with clinical followup in 100% and angiographic in 38/63.
Angiographic restenosis occurred in 27/38 (71 %) although most pa-
tients returned for followup cath secondary to symptom recurrence. Clinical
restenosis occurred in 22 (42%).
Conclusions: High risk AMI patients can be successfully treated with TEC
with a high technical success rate and a low incidence of complications.
IRA patency at 1 week and 6 months was excellent; however, angiographic
restenosis remains a problem. Extraction of thrombus in AMI may help main-
tain vessel patency but does not appear to prevent restenosis.
Pediatric Interventional Catheterization: New
Devices
Wednesday, March 22,1995,10:30 a.m.-Noon
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Clinical and Angiographic Followup to a Prospective
Study of Transluminal Extraction Atherectomy in High
Risk Patients with Acute Myocardial Infarction
Barry M. Kaplan, William W. O'Neill, Robert D. Safian, Theodore L. Schreiber,
Timothy J. Larkin, Mark Dooris, Melissa May, Cindy L. Grines. William Beaumont
Hospital, Royal Oak, Michigan
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Conclusion: Although a larger lumen was obtained with PSS and DCA, this
was not associated with a significant reduction in revascularization, recurrent
angina or death at six months. Event free survival curves reveal overlapping
and low event free survival at 3 years.
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Dilatable Prosthesis for Banding the Main Pulmonary
Artery in Children Human Clinical Trials
Dennis J. Vince, Jacques G. LeBlanc, Gordon JA Culham, Glenn P Taylor
University of British Columbia. Vancouver; British Columbia, Canada
The objective of this trial is to test the hypothesis that a prosthesis of this
design can be dilated with an intraluminal balloon dilator and is as safe and
effective to use as the conventional fixed fabric band. The design of this
trial is that of a unicenter non-randomized prospective human clinical trial.
The controls are historical. The indications for banding and the surgical tech-
niques for implantation are those previously described and accepted for con-
ventional fixed fabric bands. Dilatation employed techniques described and
accepted for balloon pulmonary valvuloplasty. During the 57 months of this
Conclusions: 1) Survival analysis estimates 93% complete PDA closure af-
ter a single coil occlusion procedure; 2) Residual shunts are associated with
larger PDA diameter, and most close spontaneously; and 3) When necessary,
a second coil occlusion has been uniformly successful.
